Target
Mitogen-activated protein kinase 14
Ligand
BDBM50156736
Substrate
n/a
Meas. Tech.
ChEMBL_429695 (CHEMBL904269)
IC50
1360±n/a nM
Citation
 Leftheris, KAhmed, GChan, RDyckman, AJHussain, ZHo, KHynes, JLetourneau, JLi, WLin, SMetzger, AMoriarty, KJRiviello, CShimshock, YWen, JWityak, JWrobleski, STWu, HWu, JDesai, MGillooly, KMLin, THLoo, DMcIntyre, KWPitt, SShen, DRShuster, DJZhang, RDiller, DDoweyko, ASack, JBaldwin, JBarrish, JDodd, JHenderson, IKanner, SSchieven, GLWebb, M The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase. J Med Chem 47:6283-91 (2004) [PubMed]  Article 
Target
Name:
Mitogen-activated protein kinase 14
Synonyms:
CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta
Type:
Serine/threonine-protein kinase
Mol. Mass.:
41286.76
Organism:
Homo sapiens (Human)
Description:
Q16539
Residue:
360
Sequence:
MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
  
Inhibitor
Name:
BDBM50156736
Synonyms:
3-(4-(1,4-diazepan-1-yl)-6-(((1S,2R,5S)-6,6-dimethylbicyclo[3.1.1]heptan-2-yl)methylamino)-1,3,5-triazin-2-ylamino)-4-methylbenzamide | CHEMBL222304
Type:
Small organic molecule
Emp. Form.:
C26H38N8O
Mol. Mass.:
478.6329
SMILES:
Cc1ccc(cc1Nc1nc(NC[C@@H]2CC[C@H]3C[C@@H]2C3(C)C)nc(n1)N1CCCNCC1)C(N)=O |r|
Structure:
Search PDB for entries with ligand similarity: